# Pramipexole and the Risk of Serious Adverse Events

> **NCT07382960** · — · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 1100 (actual)

## Conditions studied

- Older Adults (65 Years and Older)
- Chronic Kidney Disease (CKD)

## Interventions

- **DRUG:** Pramipexole

## Key facts

- **NCT ID:** NCT07382960
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07382960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07382960, "Pramipexole and the Risk of Serious Adverse Events". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07382960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*